ArticleBMC geriatrics2025
The latent tuberculosis infection survey using two interferon γ release assay tests among the elderly in a well-confined rural county in Eastern China.
Article in BMC geriatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundTuberculosis (TB) latent infection is a crucial precursor to the development of active pulmonary tuberculosis while currently no gold standard for detecting latent infection. This study aims to investigate the prevalence of latent infection among the elderly in high-incidence areas in Eastern China. Additionally, it compares the agreement of two interferon-γ release assay (IGRA) reagents in detecting latent TB infection in this elderly population.
methodsA random sampling method was adopted to select two townships from Lanxi City, China. Based on the health check-ups for the elderly under the National Basic Public Health Service Project, a questionnaire survey and latent infection testing were conducted among the recruited elderly population aged 65 and above. A multi-factor analysis was used to identify the influencing factors for latent infections in the elderly population. Meanwhile, the optimal cutoff value was determined using the ROC curve.
resultsThis study enrolled a total of 1,583 elderly individuals aged 65 years and above for latent tuberculosis infection (LTBI) testing. Among them, 424 tested positive with an infection rate of 26.78%. Multivariable analysis revealed that smoking (Adjusted OR = 1.810, 95% CI 1.315-2.491) and engaging in physical exercise at least once per week (Adjusted OR = 2.179, 95% CI 1.021-4.051) were significantly positively associated with LTBI. The comparative study of latent infection using two different reagents was conducted among 108 elderly participants, showing an extremely high level of agreement with a Kappa value of 0.812, a correlation coefficient (R²) of 0.713 (P < 0.001).Using the traditional IGRA as a reference, we found that in the elderly population, increasing the cutoff value of the domestic AIMTB reagent to 24.02 could achieve the optimal cutoff value with the area under the ROC curve 0.952, with a sensitivity of 83.3% and a specificity of 97.4%.
conclusionThe prevalence of LTBI among individuals aged 65 and above in the relatively confined rural areas of Zhejiang Province was as high as 26.78%, which required focused attention with the intensification of population aging. Male sex, smoking duration, and exercise frequency were all associated with LTBI, and the underlying mechanisms needed to be explored in the future. The domestic reagent AIMTB of China showed good agreement with IGRA reagents in old adults, which offered a model for tailoring cutoff thresholds to specific populations, helping reduce LTBI screening costs in low- and middle-income countries. Besides, the need to appropriately raise diagnostic standards should be further verified through large-scale population studies in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.